hepatosplenic T-cell lymphoma (HSTCL)

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

Pathology

  • aggressive (fast-growing) cancer
  • usually fatal

Clinical manifestations

More general terms

References

  1. FDA MedWatch: April 14, 2011 & Nov 4, 2011 Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: Update on Reports of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm251443.htm